España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Corcept Therapeutics
CORT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$51.40
0.25
0.49%
At close: -
$52.55
1.15
2.24%
After Hours: Dec 20, 4:24 PM EDT
Get Report
Comment
Corcept Therapeutics (CORT) Forecast
News
Earnings
Corcept Therapeutics (CORT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Corcept Therapeutics (NASDAQ:CORT) Stock
Corcept Therapeutics Stock (NASDAQ: CORT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
Corcept Therapeutics Presents Phase 3 Long-Te...
Benzinga Newsdesk
Friday, December 13, 2024
Corcept Therapeutics' FDA-Approved Korlym Hits Main Goal In Cushing's Syndrome Patients With Difficult-To-Control Diabetes
Vandana Singh
Thursday, December 12, 2024
Corcept Announces Primary Endpoint Met In Tre...
Benzinga Newsdesk
Corcept Therapeutics shares are trading lower...
Benzinga Newsdesk
Wednesday, December 11, 2024
Corcept Announces Results From Phase 2 Study ...
Benzinga Newsdesk
Sunday, December 08, 2024
President-Elect Trump Said He Will Not Restri...
Benzinga Newsdesk
Wednesday, November 27, 2024
Gary Charles Robb Takes Money Off The Table, Sells $146K In Corcept Therapeutics Stock
Benzinga Insights
Thursday, October 31, 2024
HC Wainwright & Co. Reiterates Buy on Corcept...
Benzinga Newsdesk
Wednesday, October 30, 2024
Corcept Therapeutics shares are trading lower...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Corcept Therapeutics Sees 2024 Revenue $675M-...
Benzinga Newsdesk
Corcept Therapeutics Q3 2024 GAAP EPS $0.41 B...
Benzinga Newsdesk
Tuesday, October 29, 2024
Earnings Preview: Corcept Therapeutics
Benzinga Insights
Friday, October 18, 2024
Key Takeaways From Corcept Therapeutics Analyst Ratings
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Corcept ...
Benzinga Newsdesk
Monday, September 30, 2024
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
Vandana Singh
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Truist Securities Maintains Buy on Corcept Th...
Benzinga Newsdesk
Thursday, September 19, 2024
Corcept Moves 6.5% Higher: Will This Strength Last?
Zacks
Wednesday, September 18, 2024
Forecasting The Future: 6 Analyst Projections For Corcept Therapeutics
Benzinga Insights
Piper Sandler Maintains Overweight on Corcept...
Benzinga Newsdesk
Tuesday, September 03, 2024
Corcept Shares Rise More Than 45% in Six Months: Here's Why
Zacks
Thursday, August 29, 2024
Insider Decision: Gary Charles Robb Offloads $110K Worth Of Corcept Therapeutics Stock
Benzinga Insights
Tuesday, August 06, 2024
Engaging In Options Activity, Hazel Hunt Exercises Options Valued At $1.77M In Corcept Therapeutics
Benzinga Insights
Wednesday, July 31, 2024
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Corcept Th...
Benzinga Newsdesk
Tuesday, July 30, 2024
Canaccord Genuity Maintains Buy on Corcept Th...
Benzinga Newsdesk
Unveiling 8 Analyst Insights On Corcept Therapeutics
Benzinga Insights
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Corcept...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Corcept ...
Benzinga Newsdesk
Monday, July 29, 2024
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Corcept Therapeutics Raises 2024 Revenue Guid...
Benzinga Newsdesk
Corcept Therapeutics Q2 2024 GAAP EPS $0.32 B...
Benzinga Newsdesk
Thursday, July 11, 2024
Zevra Rises on Update on Niemann-Pick Disease Type C Drug
Zacks
Monday, July 01, 2024
Piper Sandler Reiterates Overweight on Corcep...
Benzinga Newsdesk
Monday, June 24, 2024
Corcept Therapeutics Announces Results From C...
Benzinga Newsdesk
Monday, June 17, 2024
6 Analysts Have This To Say About Corcept Therapeutics
Benzinga Insights
Truist Securities Maintains Buy on Corcept Th...
Benzinga Newsdesk
Friday, June 14, 2024
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know
Vaishali Prayag
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Corcept Therapeutics shares are trading lower...
Benzinga Newsdesk
Reported Late Thursday: Teva Sues Corcept Ove...
Benzinga Newsdesk
Friday, June 07, 2024
Witnessing An Insider Decision, Gary Charles Robb Exercises Options Valued At $443K At Corcept Therapeutics
Benzinga Insights
Tuesday, June 04, 2024
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Corcept T...
Benzinga Newsdesk
Monday, June 03, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Corcept Therapeutics To Present Results Of Ph...
Benzinga Newsdesk
Wednesday, May 29, 2024
Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Corcept...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch